VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc.

VIAP - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$10.28K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
VIA Pharmaceuticals, Inc.VIA Pharmaceuticals, Inc.0-52%--0.8

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$10,279.00
Enterprise Value$13.93 Million
Earnings per Share$-0.47
Beta-0.6
Outstanding Shares20,452,332

Return

Return on Equity51.91%ROE
Return on Assets-1920.37%
Return on Invested Capital31.99%

Valuation & Multiples

P/E Ratio0P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-2.36
Enterprise Value to Net Income-2
Total Debt to Enterprise1.01
Debt to Equity-0.76Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About VIA Pharmaceuticals, Inc.

6 employees
CEO: Thomas Quertermous

VIA Pharmaceuticals, Inc. is an emerging biotechnology company primarily focused on discovering and advancing therapeutic compounds for cardiovascular and metabolic disorders. The firm is building a portfolio of small-molecule drug candi...